178215-45-7

Basic information

• Product Name: ALLYL 4-BROMOBUTYRATE
• Synonyms: ALLYL 4-BROMOBUTYRATE;4-bromobutyric acid allyl ester;Butanoic acid,4-broMo-, 2-propen-1-yl ester
• CAS NO: 178215-45-7
• Molecular Formula: C₇H₁₁BrO₂
• Molecular Weight: 207.07
• EINECS: -0
• Mol File: 178215-45-7.mol

Chemical Properties

• Boiling Point: 230°Cat760mmHg
• Flash Point: 92.9°C
• Appearance: /
• Density: 1.328g/cm³
• Vapor Pressure: 0.0676mmHg at 25°C
• Refractive Index: 1.4725
• BRN: 6123031
• CAS DataBase Reference: ALLYL 4-BROMOBUTYRATE(CAS DataBase Reference)
• NIST Chemistry Reference: ALLYL 4-BROMOBUTYRATE(178215-45-7)
• EPA Substance Registry System: ALLYL 4-BROMOBUTYRATE(178215-45-7)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36
• Hazardous Substances Data: 178215-45-7(Hazardous Substances Data)

Usage

Uses

Used in Food Industry:
ALLYL 4-BROMOBUTYRATE is used as a flavoring agent to enhance the taste and aroma of various food products, providing a unique and appealing flavor profile.
Used in Cosmetic Industry:
In the cosmetic industry, ALLYL 4-BROMOBUTYRATE is utilized as a fragrance ingredient, contributing to the scent of products such as perfumes, lotions, and other personal care items.
Used in Pharmaceutical Industry:
ALLYL 4-BROMOBUTYRATE is employed in the production of pharmaceuticals, where it may play a role in the development of new drugs or the enhancement of existing ones.
Used as a Chemical Intermediate in Organic Synthesis:
ALLYL 4-BROMOBUTYRATE also serves as a chemical intermediate, facilitating the synthesis of other organic compounds for various applications.
Safety Precautions:

InChI:InChI=1/C7H11BrO2/c1-2-6-10-7(9)4-3-5-8/h2H,1,3-6H2

Upstream product

• 927-58-2 4-bromobutyroyl chloride 
• 107-18-6 allyl alcohol 
• 2623-87-2 bromobutyric acid 

Downstream Products

• 3540-69-0 <4-(4-Jod-benzoyloxy)-buttersaeure>-allylester 
• 1318791-92-2 allyl-4-[6-Imino-3-(4-prop-2-ynyloxy-phenyl)-6H-pyridazin-1-yl]-butyric acid hydrobromide 
• 1318791-91-1 allyl-4-{6-imino-3-[4-(3-nitro-benzyloxy)-phenyl]-6H-pyridazin-1-yl}-butyric acid hydrobromide 
• 1318791-90-0 allyl-4-{6-imino-3-[4-(3-methoxy-benzyloxy)-phenyl]-6H-pyridazin-1-yl}-butyric acid hydrobromide 
• 1318791-89-7 allyl-4-{6-imino-3-[4-benzyloxyphenyl]-6H-pyridazin-1-yl}-butyric acid hydrobromide 

Relevant articles and documents

PD-1/PD-L1 INHIBITORS

Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.

Modular Regiospecific Synthesis of Nitrated Fatty Acids

Endogenous nitrated fatty acids are an important class of signaling molecules. Herein a modular route for the efficient and regiospecific preparation of nitrooleic acids as well as various analogues is described. The approach is based on a simple set of alkyl halides as common building blocks and a Henry reaction/Burgess dehydration sequence for the formation of the key nitroalkene moiety.

Azetidinone derivatives for the treatment of atherosclerosis

PCT No. PCT/EP95/04202 Sec. 371 Date Sep. 30, 1997 Sec. 102(e) Date Sep. 30, 1997 PCT Filed Oct. 25, 1995 PCT Pub. No. WO96/13484 PCT Pub. Date May 9, 1996Azetidinone derivatives of formula (I) in which R1 and R2, which may be the same or different, is each selected from hydrogen or C(1-8)alkyl; R3 is C(1-8)alkyl or C(3-8)cycloalkyl each of which may be optionally substituted; X is a linker group; Y is an aryl group; and n is 0, 1 or 2; and excluding benzyl (4-methylthio-2-oxo-azetidin-1-yl)acetate are inhibitors of the enzyme Lp PLA2 and are of use in therapy, in particular treating atherosclerosis.